Julie is motivated by products that tangibly improve patients’ lives. She invests in early stage biopharma and leads new company formation efforts as an executive. Prior to Canaan, she worked at Genentech across development and commercial divisions, primarily on new oncology therapies. At Canaan, Julie played an active role in the formation and launch of Nocion, Synthekine, Day One, and additional unannounced ventures. She holds an M.B.A. from Stanford, an MPhil. in BioScience Enterprise from Cambridge and a B.S. in Molecular Biophysics and Biochemistry from Yale.
Julie in 5
Origins: Grew up next to The Second City in Chicago
Interests: Maintaining a strict diet of daily dark chocolate consumption
Travel: Weekend skiing & hiking retreats in the Western mountain ranges
Accomplishments: College sailing national champion